Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05298202Phase 4Completed
Phase 4, randomised, single-blind trial of capsaicin 8% patch (2 arms), sponsored by University of Nebraska. Primary endpoints: Skin Blood Flow, Sweat Composition and 4 more. Started May 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05298202.